BONE MORPHOGENETIC PROTEIN-2 INFLUENCE ON METABOLIC ACTIVITY AND PROTEOGLYCAN SYNTHESIS BY INTERVERTEBRAL DISC CELLS
Abstract and keywords
Abstract (English):
Modern therapeutic strategies for intervertebral disc repair mainly focus on targeting molecular pathways of extracel-lular matrix degeneration. Anabolic strategies for regeneration are aimed to increase production of major extracellular molecules. Members of TGF-b superfamily proteins, particularly the bone morphogenetic proteins (BMP) have a high regenerative potential regarding the mesenchymal cells. The goal of this study is to study production of proteoglycans by the intervertebral disc cells under the influence of bone morphogenetic protein 2.Material and methods. The experiment was carried out on the cell cultures derived from the annulus fibrosis cells and nucleus pulposus cells of the human intervertebral disc. We studied cell livability, metabolic activity and proteoglycan expression. Cell livability was assessed using the trypan blue staining. Alamar blue test was used for the estimation of metabolic activity. Amount of sulfated glycosaminoglycans was assessed using the assay based on the reaction with 1,9-Dimethylmethylene Blue.Results. Cultivation with bone morphogenetic protein 2 in different concentrations did not decrease livability of the cells. Study cell cultures with application of bone morphogenetic protein 2 in different concentrations showed significant increase in metabolic activity and proteoglycan synthesis by the annulus fibrosis cells. Despite the relative increase in the number of the nucleus pulposus cells treated with the bone morphogenetic protein 2, the differences in metabolic and synthetic activity compared with control group was not significant. Conclusion. The bone morphogenetic protein 2 has an anabolic effect towards the intervertebral disc cells, particularly in the production of proteoglycans by the annulus fibrosis cells.

Keywords:
intervertebral disc, degeneration, bone morphogenetic protein, proteoglycans
References

1. BulatovAA, Savel›evVI, KalininAV (2005). Experimen-tal and clinical use of bone morphogenetic proteins [Prime-nenie kostnykh morfogeneticheskikh belkov v eksperimente i klinike]. Travmatologiya i ortopediya Rossii, (1), 46-52.

2. ByvaltsevVA, BelykhEG, StepanovIA, GiersM, PreulM (2015). Cytokine mechanisms of intervertebral disc degeneration [Tsitokinovye mekhanizmy degeneratsii mezhpozvonkovogo diska]. Sibirskiy meditsinskiy zhurnal (Irkutsk), (5), 17-21.

3. BelykhE, GiersM, BardonovaL, TheodoreN, PreulM, Byvaltsev V (2015). The role of bone morphoge-netic proteins 2, 7, and 14 in approaches for intervertebral disk restoration. World Neurosurg., 84(4), 870-877.

4. Coulson-ThomasV, GesteiraTF (2014). Dimeth-ylmethylene Blue Assay (DMMB).Bio-protocol, 4(18), e1236. Available at: http://www.bio-protocol.org/e1236.

5. FarndaleRW, ButtleDJ, BarrettAJ (1986). Im-proved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta., (883), 173-177.

6. GantenbeinB, Illien-JüngerS, ChanSC, WalserJ, HaglundL, FergusonSJ, IatridisJC, GradS (2015). Organ culture bioreactors - platforms to study human interver-tebral disc degeneration and regenerative therapy. Curr. Stem. Cell Res. Ther., 10(4), 339-352.

7. HaschtmannD, FergusonSJ, StoyanovJV (2012). BMP-2 and TGF-β3 do not prevent spontaneous degener-ation in rabbit disc explants but induce ossification of the annulus fibrosus. Eur. Spine J., 21(9), 1724-1733

8. HuangYC, UrbanJP, LukKD (2014). Intervertebral disc regeneration: do nutrients lead the way? Nat. Rev. Rheumatol., 10(9), 561-566.

9. KraemerJ (2009). Intervertebral disk diseases: causes, diagnosis, treatment, prophylaxis, 368.

10. Le MaitreCL, RichardsonSM, BairdP, Free-montAJ, HoylandJA (2005). Expression of receptors for putative anabolic growth factors in human intervertebral disc: implications for repair and regeneration of the disc.J.Pathol., 207(4), 445-452.

11. LoKW, UleryBD, AsheKM, LaurencinCT (2012). Studies of bone morphogenetic protein-based surgical repair. Adv. Drug. Deliv. Rev., 64(12), 1277-1291.

12. LouisKS, SiegelAC (2011). Cell viability analysis using trypan blue: manual and automated methods. Meth-ods Mol. Biol., (740), 7-12.

13. NolanJS, PackerL (1974). Monolayer culture techniques for normal human diploid fibroblasts. Meth. Enzymol., 32 (B), 561-568.

14. RajPP (2008). Intervertebral disc: anatomy-physiology-pathophysiology-treatment, Pain Pract., (8), 18-44.

15. TomaszewskiKA, WalochaJA, MiziaE, Gla-dyszT, GlowackiR,T omaszewskaR (2015). Age- and degeneration-related variations in cell density and glycosaminoglycan content in the human cervical in-tervertebral disc and its endplates. Pol. J. Pathol., 66(3), 296-309.

16. UrbanJP, SmithS, FairbankJC (2004). Nutrition of the intervertebral disc, Spine (Phila Pa 1976), (29), 2700-2709.

Login or Create
* Forgot password?